Matching slides 58,039
Current window 28,801-28,830
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all

Slide function

28,801-28,830 of 58,039

filter-aware
11
Includes footnotes regarding Bausch Health name change and non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
Data presented as bar charts for three products across two metrics (TRx and NRx).Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
Includes specific product performance metrics (Evolution Index) for Canada, EMEA, and Latin America.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
Includes footnotes referencing non-GAAP measures and segment reporting.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses a grid of six charts to demonstrate positive performance across contact lenses, Vyzulta, consumer products, Lumify, Stellaris Elite, and international surgical revenue.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
19
The table includes a footnote regarding non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
20
The slide includes detailed footnotes regarding non-GAAP measures, share counts, and specific exclusions.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
21
The slide highlights the difference between GAAP operating cash flow and adjusted non-GAAP cash flow, specifically noting the impact of legacy legal settlements.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
22
Includes detailed footnotes regarding debt composition and non-GAAP adjustments.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
24
The slide uses a before-and-after comparison to highlight the impact of a corporate action (B&L IPO) on debt structure.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations Loop · Before After1 hit
25
The chart shows mandatory amortization payments from 2022-2026 and a large bullet maturity in 2027.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations Loop · Before After1 hit
28
The slide includes a specific callout box on the right for additional key metrics and dis-synergy impact.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
36
The table tracks inventory levels across two distinct periods (Dec 31 to Mar 31) for two consecutive years.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
37
The slide compares the debt maturity schedule as of March 31, 2022, against a pro forma scenario involving B+L IPO proceeds and refinancings.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
38
The slide provides a clear breakdown of debt obligations over a 6-year period.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
39
Includes non-GAAP measures; references constant currency and tax rate calculations.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
41
The table provides a detailed breakdown of adjustments to reconcile GAAP net income to non-GAAP adjusted net income.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
42
The slide presents two separate tables for YTD 2022 and YTD 2021, detailing adjustments like amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
43
The table provides a bridge from GAAP net loss to non-GAAP Adjusted EBITDA.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
44
Includes detailed breakdown of currency impacts, divestitures, and growth percentages by segment.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
45
The table includes adjustments for exchange rates, divestitures, and discontinuations to arrive at organic revenue figures.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
46
The slide provides a bridge between GAAP operating cash flow and a non-GAAP adjusted metric.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
47
The table provides a detailed breakdown of adjustments including impairments, restructuring, debt extinguishment, and other operational costs.Bausch Health Companies | Results Presentation Deck | 53 slides · Bausch Health
Conference presentation Investor relations 1 hit
04
The slide uses a decision tree structure to map patient cohorts to clinical outcomes and progression status.BioAtla | Results Presentation Deck | 9 slides · BioAtla
Conference presentation Investor relations Beat · KPI Overview1 hit
05
Includes a spider plot for lesion changes and a Kaplan-Meier curve for PFS.BioAtla | Results Presentation Deck | 9 slides · BioAtla
Conference presentation Investor relations Beat · KPI Overview1 hit
06
Includes a comparison to historical placebo data at the bottom.BioAtla | Results Presentation Deck | 9 slides · BioAtla
Conference presentation Investor relations Beat · KPI Overview1 hit
08
Includes specific AE breakdown for Constipation, Peripheral Neuropathy, and Diarrhea.BioAtla | Results Presentation Deck | 9 slides · BioAtla
Conference presentation Investor relations 1 hit
14
The chart uses a vertical dashed line to mark the 'New product roadmap launches' event in 2020 Q2.Blue Apron | Investor Day Presentation Deck | 135 slides · Blue Apron
Conference presentation Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
15
The chart uses a vertical dashed line to mark the 'New product roadmap launches' event.Blue Apron | Investor Day Presentation Deck | 135 slides · Blue Apron
Conference presentation Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
16
The chart uses a vertical dashed line to denote a specific event (product roadmap launch) that correlates with a shift in the trend line.Blue Apron | Investor Day Presentation Deck | 135 slides · Blue Apron
Conference presentation Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit